BETA
Early release — we are building new features fast, you may encounter issues. Help us improve:
contact us
to report bugs or share feedback.
✕
Loading...
Analytics
Equity Analytics
On the record this week: what the Street published, what insiders filed, and what reports next.
←
Back to Equity Analytics
Equity Analytics
/
BAYN.DE
BAYN.DE
Bayer Aktiengesellschaft
Healthcare - DE
Bayer AG Bayer Aktiengesellschaft (BAYN.DE) is a German multinational life sciences company that develops, manufactures and markets products in pharmaceuticals; consumer health, including non-prescription medicines, nutritional supplements,…
Show more
HQ: Leverkusen, NW, Germany
www.bayer.com
EUR
48.70
-1.14%
vs prev. close
Overview
Fundamentals
Ownership & Activity
Analyst Consensus
Seasonality & Patterns
News
Research
Market snapshot
Price
EUR
48.70
Daily move
-1.14%
P/E
—
EPS TTM
-1.76
Dividend yield
0.23%
Beta
0.83
Market cap
55.0B
Price history
BAYN.DE price
EUR
Line
Candle
Volume
Log scale
1m
3m
6m
1y
3y
5y
10y
max
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Valuation & performance
Risk
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Bayer
BAYN.DE
Drug Manufacturers - General
55.0
—
0.23%
-1.3%
-0.5%
+36.1%
+24.5%
+73.7%
+31.6%
🔒
Subscribe to Equity Analytics to compare BAYN.DE with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.
View plans
Ask Ashenden
One question, one concise answer grounded in Ashenden research.
Ask
Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.
Is BAYN.DE cheap or expensive against its peers, and what justifies the gap?
What does the price already assume about BAYN.DE?
What would have to go wrong for BAYN.DE from here?
Why BAYN.DE now, and not a year ago?